Schwartz,RA;McDonough,PH;Lee,BW(August 2013).«Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.».Journal of the American Academy of Dermatology69(2): 173.e1–13; quiz 185–6.doi:10.1016/j.jaad.2013.05.003.PMID23866878.
«Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis».Clinical Reviews in Allergy & Immunology54(1): 147–176.2017.doi:10.1007/s12016-017-8654-z.PMID29188475.
«Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist».Current Rheumatology Reports19(1): 3.January 2017.doi:10.1007/s11926-017-0626-z.PMID28138822.
Tan SK, Tay YK;Tay(2012).«Profile and pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a general hospital in Singapore: Treatment outcomes».Acta Dermato-Venereologica92(1): 62–6.doi:10.2340/00015555-1169.PMID21710108.
Teraki Y, Shibuya M, Izaki S;Shibuya;Izaki(2010).«Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations».Clin. Exp. Dermatol.35(7): 723–8.doi:10.1111/j.1365-2230.2009.03718.x.PMID19874350.
Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC;Mockenhaupt;Bouwes-Bavinck;Naldi;Viboud;Roujeau;Euroscar Study(2001).«Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis».AIDS15(14): 1843–8.doi:10.1097/00002030-200109280-00014.PMID11579247.
Trujillo C, Gago C, Ramos S;Gago;Ramos(2010).«Stevens-Jonhson syndrome after acetaminophen ingestion, confirmed by challenge test in an eleven-year-old patient».Allergol Immunopathol (Madr)38(2): 99–100.doi:10.1016/j.aller.2009.06.009.PMID19875224.
«Pustular psoriasis and related pustular skin diseases».The British Journal of Dermatology178(3): 614–618.January 2018.doi:10.1111/bjd.16232.PMID29333670.
«Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms».International Archives of Allergy and Immunology171(3–4): 166–179.2016.doi:10.1159/000453265.PMID27960170.
«Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions».Current Opinion in Allergy and Clinical Immunology16(4): 339–45.2016.doi:10.1097/ACI.0000000000000286.PMID27362322.
Schwartz,RA;McDonough,PH;Lee,BW(August 2013).«Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.».Journal of the American Academy of Dermatology69(2): 173.e1–13; quiz 185–6.doi:10.1016/j.jaad.2013.05.003.PMID23866878.
«Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis».Clinical Reviews in Allergy & Immunology54(1): 147–176.2017.doi:10.1007/s12016-017-8654-z.PMID29188475.
«Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist».Current Rheumatology Reports19(1): 3.January 2017.doi:10.1007/s11926-017-0626-z.PMID28138822.
Tan SK, Tay YK;Tay(2012).«Profile and pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a general hospital in Singapore: Treatment outcomes».Acta Dermato-Venereologica92(1): 62–6.doi:10.2340/00015555-1169.PMID21710108.
Teraki Y, Shibuya M, Izaki S;Shibuya;Izaki(2010).«Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations».Clin. Exp. Dermatol.35(7): 723–8.doi:10.1111/j.1365-2230.2009.03718.x.PMID19874350.
Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC;Mockenhaupt;Bouwes-Bavinck;Naldi;Viboud;Roujeau;Euroscar Study(2001).«Nevirapine and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis».AIDS15(14): 1843–8.doi:10.1097/00002030-200109280-00014.PMID11579247.
Trujillo C, Gago C, Ramos S;Gago;Ramos(2010).«Stevens-Jonhson syndrome after acetaminophen ingestion, confirmed by challenge test in an eleven-year-old patient».Allergol Immunopathol (Madr)38(2): 99–100.doi:10.1016/j.aller.2009.06.009.PMID19875224.
«Pustular psoriasis and related pustular skin diseases».The British Journal of Dermatology178(3): 614–618.January 2018.doi:10.1111/bjd.16232.PMID29333670.
«Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms».International Archives of Allergy and Immunology171(3–4): 166–179.2016.doi:10.1159/000453265.PMID27960170.
«Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions».Current Opinion in Allergy and Clinical Immunology16(4): 339–45.2016.doi:10.1097/ACI.0000000000000286.PMID27362322.
